Literature DB >> 3616989

Changes in bronchial responsiveness to histamine at intervals after allergen challenge.

D W Cockcroft, K Y Murdock.   

Abstract

Bronchial responsiveness to inhaled histamine was measured two, seven, and 30 hours after allergen inhalation challenge in 19 atopic subjects. The provocative histamine concentrations causing a 20% fall in FEV1 (PC20) at these three times were compared with the baseline value, with values obtained two and seven hours after diluent inhalation, and with those obtained five to seven days after allergen challenge in the 12 late responders. Seven subjects had allergen induced isolated early asthmatic responses (delta FEV1 22.6% (SD 6.6%)) with less than a 5% late fall in FEV1. There was no change in the six histamine PC20 values measured in these seven subjects; the geometric mean PC20 was 1.0-1.3 mg/ml on all six occasions. Twelve subjects had an allergen induced early asthmatic response (delta FEV1 26.3% (9.8%)) followed by a definite (greater than 15% delta FEV1, n = 7) or equivocal (5-15% delta FEV1, n = 5) late asthmatic response. The geometric mean histamine PC20 was not significantly different two hours after allergen inhalation either from baseline (0.67 v 0.78 mg/ml) or from that seen two hours after diluent (0.67 v 0.95). It was significantly reduced at seven (0.24 mg/ml) and at 30 hours (0.44 mg/ml) but had returned to baseline when repeated five to seven days later (0.74 mg/ml). In 10 subjects with a dual response who had a repeat antigen challenge the mean early and late response and delta PC20 at seven and 30 hours were similar. These data show that bronchial responsiveness to a non-allergic stimulus has not increased two hours after allergen inhalation following spontaneous recovery of the early asthmatic response but before the start of the late asthmatic response.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3616989      PMCID: PMC460713          DOI: 10.1136/thx.42.4.302

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  19 in total

1.  Bronchial provocation tests in etiologic diagnosis and analysis of asthma.

Authors:  J Pepys; B J Hutchcroft
Journal:  Am Rev Respir Dis       Date:  1975-12

2.  Bronchial reactivity to inhaled histamine: a method and clinical survey.

Authors:  D W Cockcroft; D N Killian; J J Mellon; F E Hargreave
Journal:  Clin Allergy       Date:  1977-05

Review 3.  Immunopathology of allergic lung disease.

Authors:  J Pepys
Journal:  Clin Allergy       Date:  1973-03

4.  Allergen-induced increase in non-allergic bronchial reactivity.

Authors:  D W Cockcroft; R E Ruffin; J Dolovich; F E Hargreave
Journal:  Clin Allergy       Date:  1977-11

5.  Nonspecific bronchial reactivity in occupational asthma.

Authors:  S Lam; R Wong; M Yeung
Journal:  J Allergy Clin Immunol       Date:  1979-01       Impact factor: 10.793

6.  The late phase of the immediate wheal and flare skin reaction. Its dependence upon IgE antibodies.

Authors:  G O Solley; G J Gleich; R E Jordon; A L Schroeter
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

7.  Late bronchial obstructive reaction to experimental inhalation of house dust extract.

Authors:  H Booij-Noord; K de Vries; H J Sluiter; N G Orie
Journal:  Clin Allergy       Date:  1972-03

8.  Reproducibility and comparison of responses to inhaled histamine and methacholine.

Authors:  E F Juniper; P A Frith; C Dunnett; D W Cockcroft; F E Hargreave
Journal:  Thorax       Date:  1978-12       Impact factor: 9.139

9.  Nonspecific bronchial hyperreactivity after exposure to Western Red Cedar.

Authors:  D W Cockcroft; D J Cotton; J T Mink
Journal:  Am Rev Respir Dis       Date:  1979-03

10.  Modification of bronchial hyperreactivity after treatment with sodium cromoglycate during pollen season.

Authors:  O Löwhagen; S Rak
Journal:  J Allergy Clin Immunol       Date:  1985-04       Impact factor: 10.793

View more
  8 in total

Review 1.  Measurement of airway hyperresponsiveness: new considerations.

Authors:  J Lötvall; M Inman; P O'Byrne
Journal:  Thorax       Date:  1998-05       Impact factor: 9.139

2.  Effect of inhaled leukotriene B4 alone and in combination with prostaglandin D2 on bronchial responsiveness to histamine in normal subjects.

Authors:  P N Black; R W Fuller; G W Taylor; P J Barnes; C T Dollery
Journal:  Thorax       Date:  1989-06       Impact factor: 9.139

3.  Effect of allergen challenge on airway responsiveness to histamine and sodium metabisulphite in mild asthma.

Authors:  D J Evans; L J Coulby; B J O'Connor
Journal:  Thorax       Date:  1996-12       Impact factor: 9.139

4.  Intranasal challenge with increasing ovalbumin doses differently affects airway hyperresponsiveness and inflammatory cell accumulation in mouse model of asthma.

Authors:  Berislav Bosnjak; Vanesa Ivetić Tkalcević; Koraljka Durić; Daniela Belamarić; Snjezana Cuzić; Zeljko Ferencić; Karmen Brajsa; Ines Glojnarić; Roberto Antolović; Boska Hrvacić
Journal:  Inflamm Res       Date:  2009-05-08       Impact factor: 4.575

5.  Contrasting effects of allergen challenge on airway responsiveness to cysteinyl leukotriene D(4) and methacholine in mild asthma.

Authors:  R I Ketchell; M D'Amato; M W Jensen; B J O'Connor
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

6.  Dysfunction of muscarinic M2 receptors after the early allergic reaction: possible contribution to bronchial hyperresponsiveness in allergic guinea-pigs.

Authors:  R E ten Berge; R E Santing; J J Hamstra; A F Roffel; J Zaagsma
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

7.  Long-term intense exposure to grass pollen can mask positive effects of allergenic immunotherapy on non-specific bronchial hyperresponsiveness.

Authors:  Ewa M Swiebocka; Piotr Siergiejko; Piotr Rapiejko; Zenon Siergiejko
Journal:  Arch Med Sci       Date:  2014-08-29       Impact factor: 3.318

8.  Th17/Treg ratio derived using DNA methylation analysis is associated with the late phase asthmatic response.

Authors:  Amrit Singh; Masatsugu Yamamoto; Jian Ruan; Jung Young Choi; Gail M Gauvreau; Sven Olek; Ulrich Hoffmueller; Christopher Carlsten; J Mark FitzGerald; Louis-Philippe Boulet; Paul M O'Byrne; Scott J Tebbutt
Journal:  Allergy Asthma Clin Immunol       Date:  2014-06-24       Impact factor: 3.406

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.